Hydroxychloroquine retinopathy: screening and genetics

Eye (Lond). 2021 May;35(5):1522-1523. doi: 10.1038/s41433-020-0976-z. Epub 2020 May 28.

Authors

F H Zaidi¹, C A Rennie², A K Drinkwater², D Sahu², E Akyol^{2

3}, A J Lotery^{2

3}

Affiliations

¹ Department of Ophthalmology, University of Southampton NHS Foundation Trust, Southampton, UK. fhz12@hotmail.com.
² Department of Ophthalmology, University of Southampton NHS Foundation Trust, Southampton, UK.
³ Faculty of Medicine, University of Southampton, Southampton, UK.

No abstract available

Publication types

Letter

MeSH terms

Antirheumatic Agents* / adverse effects
Humans
Hydroxychloroquine / adverse effects
Retinal Diseases* / chemically induced
Retinal Diseases* / diagnosis
Retinal Diseases* / genetics
Tomography, Optical Coherence
Visual Field Tests

Substances

Antirheumatic Agents
Hydroxychloroquine